Skip to Content

Logo 2839 Logo 2839 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint Logo 2839 Logo 2839 is Brown & Yellow, Capsule-shape and has been identified as Fenofibric acid delayed-release 135 mg. It is supplied by Actavis Pharma, Inc..

Fenofibric acid is used in the treatment of high cholesterol; hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 2839 Logo 2839

Fenofibric acid delayed-release

Logo 2839 Logo 2839
135 mg
Brown & Yellow
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.